newsfilter
← Latest News
PR Newswire·

Lipocine Appoints Michael J. Grissinger to Board of Directors

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...